Operating Income (Loss) of Quantumzyme Corp. from 31 Jul 2024 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Quantumzyme Corp. quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Jul 2024 to 31 Oct 2025.
Quantumzyme Corp. Operating Income (Loss) for the quarter ending 31 Oct 2025 was $39,196, a 36% increase year-over-year.
Quantumzyme Corp. annual Operating Income (Loss) for 2025 was $180,537, a 10% decline from 2024.
Source SEC data: View on sec.gov

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Change (%)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Change (%)

Quantumzyme Corp. Quarterly Operating Income (Loss) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025		$39,196	+$21,738	+36%	01 Aug 2025	31 Oct 2025	10-Q	15 Dec 2025	2026	Q1
Q3 2024		$60,934			01 Aug 2024	31 Oct 2024	10-Q	15 Dec 2025	2026	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$180,537	-$16,944	-10%	01 Aug 2024	31 Jul 2025	10-K/A	17 Nov 2025	2025	FY
2024	$163,593			01 Aug 2023	31 Jul 2024	10-K/A	17 Nov 2025	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.